University of Cincinnati researchers working on pancreatic cancer antibody

CINCINNATI – University of Cincinnati researchers are working on a way to stop the growth of pancreatic cancer, according to our news partner WCPO.
UC College of Medicine researcher Vladimir Bogdanov will use a $300,000 grant from the Pancreatic Cancer Action Network to continue his research to develop an antibody that reduces the growth of pancreatic tumor cells.

WCPO reported Bogdanov said tumor cells often hijack vascular networks to fuel their own growth, and his RabMab1antibody targets a protein that promotes the growth of those networks.

The grant money will be used to further refine RabMab1 and clinical trials involving animals, according to the WCPO news report.

About the Author